The Bulletin
The Times


.

First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT

  • Written by PR Newswire
First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT

SYDNEY, May 29, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that it has imaged the first patient in its registrational Phase III 6...

hacklink esim balkanSahabetuk casinos not on gamstopGamStopgrandpashabet girisjojobetviagra 100 mg fiyat